|
1
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee AW, Ng WT, Chan YH, Sze H, Chan C and
Lam TH: The battle against nasopharyngeal cancer. Radiother Oncol.
104:272–278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hwang CF, Huang HY, Chen CH, Chien CY, Hsu
YC, Li CF and Fang FM: Enhancer of zeste homolog 2 overexpression
in nasopharyngeal carcinoma: An independent poor prognosticator
that enhances cell growth. Int J Radiat Oncol Biol Phys.
82:597–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang CJ and Hung MC: The role of EZH2 in
tumour progression. Br J Cancer. 106:243–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crea F, Paolicchi E, Marquez VE and Danesi
R: Polycomb genes and cancer: Time for clinical application. Crit
Rev Oncol Hematol. 83:184–193. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi Y, Pontrello CG, DeFea KA, Reichardt
LF and Ethell IM: Focal adhesion kinase acts downstream of EphB
receptors to maintain mature dendritic spines by regulating cofilin
activity. J Neurosci. 29:8129–8142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Newell-Litwa KA, Badoual M, Asmussen H,
Patel H, Whitmore L and Horwitz AR: ROCK1 and 2 differentially
regulate actomyosin organization to drive cell and synaptic
polarity. J Cell Biol. 210:225–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen
J, Guo S and Hisamitsu T: Antimetastatic effects of Celastrus
orbiculatus on human gastric adenocarcinoma by inhibiting
epithelial-mesenchymal transition and NF-κB/snail signaling
pathway. Integr Cancer Ther. 14:271–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Qian Y, Liu Y, Li G, Cui P, Zhu
Y, Ma H, Ji X, Guo S and Tadashi H: Celastrus orbiculatus
extract induces mitochondrial-mediated apoptosis in human
hepatocellular carcinoma cells. J Tradit Chin Med. 32:621–626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian YY, Zhang H, Hou Y, Yuan L, Li GQ,
Guo SY, Hisamits T and Liu YQ: Celastrus orbiculatus extract
inhibits tumor angiogenesis by targeting vascular endothelial
growth factor signaling pathway and shows potent antitumor activity
in hepatocarcinomas in vitro and in vivo. Chin J Integr Med.
18:752–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li JJ, Yang J, LÜ F, Qi YT, Liu YQ, Sun Y
and Wang Q: Chemical constituents from the stems of Celastrus
orbiculatus. Chin J Nat Med. 10:pp279–283. 2012. View Article : Google Scholar
|
|
12
|
Zan K, Chen XQ, Wang Q and Cao L: Chemical
constituents in stem of Celastrus orbiculatus. Chin Trad
Herbal Drugs. 38:1455–1457. 2007.
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen
J, Guo S and Hisamitsu T: Research on the efficacy of Celastrus
Orbiculatus in suppressing TGF-β1-induced
epithelial-mesenchymal transition by inhibiting HSP27 and
TNF-α-induced NF-κ B/Snail signaling pathway in human gastric
adenocarcinoma. BMC Complement Altern Med. 14:4332014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Zhao H, Lv L, Bao L, Wang X and
Han S: Prognostic significance of EZH2 expression in non-small cell
lung cancer: A meta-analysis. Sci Rep. 6:192392016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rabello Ddo A, Lucena-Araujo AR,
Alves-Silva JC, da Eira VB, de Vasconcellos MC, de Oliveira FM,
Rego EM, Saldanha-Araujo F and Silva Pittella F: Overexpression of
EZH2 associates with a poor prognosis in chronic lymphocytic
leukemia. Blood Cells Mol Dis. 54:97–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song X, Gao T, Wang N, Feng Q, You X, Ye
T, Lei Q, Zhu Y, Xiong M, Xia Y, et al: Selective inhibition of
EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent
anti-tumor activity in breast cancer. Sci Rep. 6:208642016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Croft DR, Crighton D, Samuel MS, Lourenco
FC, Munro J, Wood J, Bensaad K, Vousden KH, Sansom OJ, Ryan KM and
Olson MF: p53-mediated transcriptional regulation and activation of
the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway
promotes cell survival. Cell Res. 21:666–682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL and
Der CJ: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Ye L, Zhang L and Jiang WG:
Placenta growth factor, PLGF, influences the motility of lung
cancer cells, the role of Rho associated kinase, Rock1. J Cell
Biochem. 105:313–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Girard N, Bazille C, Lhuissier E, Benateau
H, Llombart-Bosch A, Boumediene K and Bauge C: 3-Deazaneplanocin A
(DZNep), an inhibitor of the histone methyltransferase EZH2,
induces apoptosis and reduces cell migration in chondrosarcoma
cells. PLoS One. 9:e981762014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Zhao FP, Peng Z, Zhang MW, Lin SX,
Liang BJ, Zhang B, Liu X, Wang L, Li G, et al: EZH2 promotes
angiogenesis through inhibition of miR-1/Endothelin-1 axis in
nasopharyngeal carcinoma. Oncotarget. 5:11319–11332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ,
Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, et al: EZH2 supports
nasopharyngeal carcinoma cell aggressiveness by forming a
co-repressor complex with HDAC1/HDAC2 and snail to inhibit
E-cadherin. Oncogene. 31:583–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
